Ciproxifan maleate - CAS# 184025-19-2 osapride It can cause the symptoms

It can cause the symptoms of diarrhoea and myelosuppression experienced by ~25% of the patients administered irinotecan

1 fmole/nucleus of methylproamine is required to achieve a substantial level of radioprotection (DMF of 1

SSTC3 (25 mg/kg

It is not approved for the clinical treatment of major depressive disorder in the USA

ClH/c11-6-1-2-7-5(9(6)12)3-15-4-8(16)14-10(15)13-7

Ciproxifan maleate - CAS# 184025-19-2 osapride It can cause the symptomsCiproxifan, also known as FUB 359, is an extremely potent histamine H3 inverse agonist antagonist. Ciproxifan produces wakefulness and attentiveness in animal studies, and produced cognitive enhancing effects without prominent stimulant effects at relatively low levels of receptor occupancy, and pronounced wakefulness at higher doses. It has therefore been proposed as a potential treatment for sleep disorders such as narcolepsy and to improve